Title : Combination therapy with an HMG-CoA reductase inhibitor and a fibric acid derivative: a critical review of potential benefits and drawbacks.

Pub. Date : 2003

PMID : 14727929






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The use of combined therapy with an HMG-CoA reductase inhibitor and a fibric acid derivative requires the respect of some rules such as avoiding the prescription in patients with concomitant conditions like renal failure and avoiding the use of gemfibrozil as a fibric acid derivative in such a combination. Gemfibrozil 3-hydroxy-3-methylglutaryl-CoA reductase Homo sapiens